Tegaserod Maleate

CHEMBL1516474 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
417.5 g/mol
LogP
Phase
4

Tegaserod maleate is the maleate salt form of tegaserod, a 5-HT4 receptor partial agonist used for irritable bowel syndrome with constipation. See tegaserod for complete pharmacological details. This salt form provides improved stability and bioavailability in oral formulations.

Peso molecular

417,5000 g/mol

TPSA

162,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\C(=O)O

InChI

InChI=1S/C16H23N5O.C4H4O4/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15;5-3(6)1-2-4(7)8/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21);1-2H,(H,5,6)(H,7,8)/b20-11+;2-1-

Molecular Formula

C20H27N5O5

HBD / HBA

5 / 7

Enlaces Rotables

10

Átomos Pesados

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Tegaserod maleate is the maleate salt form of tegaserod, a 5-HT4 receptor partial agonist used for irritable bowel syndrome with constipation. See tegaserod for complete pharmacological details. This salt form provides improved stability and bioavailability in oral formulations.

Yes, Tegaserod Maleate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1516474. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135413539. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.